Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ONCT-808 |
Trade Name | |
Synonyms | ONCT808|ONCT 808 |
Drug Descriptions |
ONCT-808 are autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) that targets ROR1, potentially resulting in cytotoxicity against tumor cells expressing ROR1 (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C199660 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ONCT-808 | ONCT-808 | 0 | 1 |